Demonstration to Increase Hydroxyurea Prescribing for Children with Sickle Cell Disease Through Provider Incentives

This notice solicits applications to demonstrate the feasibility and effectiveness of providing financial incentives to providers to improve the quality of life of children with sickle cell disease (SCD) through increased prescription rates of hydroxyurea. This initiative is not issued or funded by the Centers for Medicare and Medicaid Services (CMS).

• State Governments • County Governments • City or township governments • Special district governments • Independent school districts • Public and State controlled institutions of higher education • Native American tribal governments (Federally recognized) • Public Housing authorities/Indian housing authorities • Native American tribal organizations (other than federally recognized tribal governments) • Nonprofits having 501(c)(3) status with the IRS, other than institutions of higher education • Nonprofits without 501(c)(3) status with the IRS, other than institutions of higher education • Private non-profit institutions of higher education • U.S. Territories

Grants.gov Contact Center Phone Number: 1-800-518-4726 Hours of operation are 24 hours a day, 7 days a week. The contact center is closed on federal holidays. support@grants.gov